{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:35:19Z","timestamp":1762875319389},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T00:00:00Z","timestamp":1272585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10096-010-0945-8","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T19:01:14Z","timestamp":1272567674000},"page":"749-754","source":"Crossref","is-referenced-by-count":11,"title":["Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany"],"prefix":"10.1007","volume":"29","author":[{"given":"M.","family":"Linden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. R.","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,30]]},"reference":[{"key":"945_CR1","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2006.09.027","volume":"25","author":"MA Fletcher","year":"2007","unstructured":"Fletcher MA, Fritzell B (2007) Brief review of the clinical effectiveness of PREVENAR\u00ae against otitis media. Vaccine 25:2507\u20132512","journal-title":"Vaccine"},{"key":"945_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/380642","volume":"38","author":"AAI Palmu","year":"2004","unstructured":"Palmu AAI, Herva E, Savolainen H, Karma P, Makela PH, Kilpi TM (2004) Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 38:234\u2013242","journal-title":"Clin Infect Dis"},{"key":"945_CR3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00006454-200209000-00015","volume":"21","author":"SL Block","year":"2002","unstructured":"Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2002) Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21:859\u2013865","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/171.4.885","volume":"171","author":"JC Butler","year":"1995","unstructured":"Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978\u20131994: implications for development of a conjugate vaccine. J Infect Dis 171:885\u2013889","journal-title":"J Infect Dis"},{"key":"945_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","volume":"19","author":"S Black","year":"2000","unstructured":"Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187\u2013195","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","volume":"344","author":"J Eskola","year":"2001","unstructured":"Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403\u2013409","journal-title":"N Engl J Med"},{"key":"945_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","volume":"22","author":"B Fireman","year":"2003","unstructured":"Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10\u201316","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.inf.0000133049.30299.5d","volume":"23","author":"AAI Palmu","year":"2004","unstructured":"Palmu AAI, Verho J, Jokinen J, Karma P, Kilpi TM (2004) The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 23:732\u2013738","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/INF.0b013e31818e0e2e","volume":"28","author":"DS Shouval","year":"2009","unstructured":"Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2009) Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3\u00a0years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28:277\u2013282","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR10","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.vaccine.2009.04.021","volume":"27","author":"GL Rodgers","year":"2009","unstructured":"Rodgers GL, Arguedas A, Cohen R, Dagan R (2009) Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27:3802\u20133810","journal-title":"Vaccine"},{"key":"945_CR11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.inf.0000136868.91756.80","volume":"23","author":"SL Block","year":"2004","unstructured":"Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2004) Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23:829\u2013833","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.inf.0000136871.51792.19","volume":"23","author":"JR Casey","year":"2004","unstructured":"Casey JR, Pichichero ME (2004) Changes in frequency and pathogens causing acute otitis media in 1995\u20132003. Pediatr Infect Dis J 23:824\u2013828","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/379665","volume":"188","author":"MC McEllistrem","year":"2003","unstructured":"McEllistrem MC, Adams J, Mason EO, Wald ER (2003) Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 188:1679\u20131684","journal-title":"J Infect Dis"},{"key":"945_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2007-0619","volume":"121","author":"F Zhou","year":"2008","unstructured":"Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997\u20132004. Pediatrics 121:253\u2013260","journal-title":"Pediatrics"},{"key":"945_CR15","unstructured":"Claes C, Reinert RR, Vauth C, Greiner W (2008) Health Technology Assessment. Heptavalenter Pneumokokkenkonjugat-Impfstoff (PCV7). http:\/\/portal.dimdi.de\/de\/hta\/hta_berichte\/hta202_bericht_de.pdf . Accessed 26 April 2010"},{"key":"945_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1651-2227.2000.tb00777.x","volume":"435","author":"C Ziebold","year":"2000","unstructured":"Ziebold C, von Kries R, Siedler A, Schmitt HJ (2000) Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr Suppl 435:17\u201321","journal-title":"Acta Paediatr Suppl"},{"key":"945_CR17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/JCM.39.3.1187-1189.2001","volume":"39","author":"RR Reinert","year":"2001","unstructured":"Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, L\u00fctticken R (2001) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. J Clin Microbiol 39:1187\u20131189","journal-title":"J Clin Microbiol"},{"key":"945_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1469-0691.2006.01676.x","volume":"13","author":"RR Reinert","year":"2007","unstructured":"Reinert RR, van der Linden M, Seegmuller I, Al-Lahham A, Siedler A, Weissmann B, Toschke AM, von Kries R (2007) Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clin Microbiol Infect 13:363\u2013368","journal-title":"Clin Microbiol Infect"},{"key":"945_CR19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.inf.0000189985.96561.81","volume":"24","author":"A Siedler","year":"2005","unstructured":"Siedler A, Reinert RR, Toschke M, Al-Lahham A, von Kries R (2005) Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany. Pediatr Infect Dis J 24:1114\u20131115","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR20","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/s00431-002-1067-9","volume":"161","author":"R Kries von","year":"2002","unstructured":"von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR (2002) Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? Eur J Pediatr 161:S140\u2013S143","journal-title":"Eur J Pediatr"},{"key":"945_CR21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00006454-200211000-00008","volume":"21","author":"R Kries von","year":"2002","unstructured":"von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR (2002) Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 21:1017\u20131023","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/313984","volume":"31","author":"R Kries von","year":"2000","unstructured":"von Kries R, Siedler A, Schmitt HJ, Reinert RR (2000) Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482\u2013487","journal-title":"Clin Infect Dis"},{"key":"945_CR23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2005.01282.x","volume":"11","author":"RR Reinert","year":"2005","unstructured":"Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, Fedson DS (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001\u20132003. Clin Microbiol Infect 11:985\u2013991","journal-title":"Clin Microbiol Infect"},{"key":"945_CR24","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard\u20149th edition","author":"Clinical and Laboratory Standards Institute","year":"2006","unstructured":"Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial disk susceptibility tests; approved standard\u20149th edition. CLSI, Wayne, PA, USA"},{"key":"945_CR25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","volume":"368","author":"CG Whitney","year":"2006","unstructured":"Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist A-C, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumoccoccal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368:1495\u20131502","journal-title":"Lancet"},{"key":"945_CR26","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","volume":"28","author":"T Vesikari","year":"2009","unstructured":"Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene J-P, Lommel P, Dieussaert I, Schuerman L (2009) Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 28:S66\u2013S76","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","volume":"367","author":"R Prymula","year":"2006","unstructured":"Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L (2006) Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367:740\u2013748","journal-title":"Lancet"},{"key":"945_CR28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00006454-200211000-00007","volume":"21","author":"WP Hausdorff","year":"2002","unstructured":"Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J (2002) Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21:1008\u20131016","journal-title":"Pediatr Infect Dis J"},{"key":"945_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(07)70061-0","volume":"7","author":"A Vergison","year":"2007","unstructured":"Vergison A, Reinert RR (2007) Streptococcus pneumoniae incidence in Western Europe. Lancet Infect Dis 7:240\u2013242","journal-title":"Lancet Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-0945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-0945-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-0945-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:18Z","timestamp":1559122458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-0945-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,30]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-0945-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,30]]}}}